Comments of the Healthcare Supply Chain Association (HSCA) on USTR Request for Comments on the Proposed Modification of Action Pursuant to Section 301
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. Trade Representative (USTR) on the proposed modification of action regarding Chinese exports under Section 301.
Click here for the full comments.
Related Posts
HSCA Letter to the House Committee on Energy and Commerce
July 30, 2020
Dear Chairman Pallone and Ranking Member Walden: On behalf of the Healthcare...
HSCA Comments to the U.S. ITC on COVID-19 Related Goods: The U.S. Industry, Market, Trade, and Supply Chain Challenges
October 5, 2020
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...
HSCA Submits Comments to FDA on Using Unique Device Identifiers in Medical Device Safety Communications to Support Accuracy, Quality, and Patient Safety
January 18, 2021
Washington, DC (January 19, 2021) – The Healthcare Supply Chain Association...
Comments of the Healthcare Supply Chain Association (HSCA) on FDA Request for Comments on Ensuring a Competitive Marketplace for Biosimilars
April 10, 2020
On behalf of the Healthcare Supply Chain Association (HSCA), we...